China's Tongce Medical announced that its operating revenue for the third quarter of 2026 was RMB 915 million, a year-on-year increase of 2.93%. Net profit attributable to shareholders of listed companies was RMB 212 million, a year-on-year increase of 3.21%. Net profit excluding non-recurring gains and losses was RMB 212 million, a year-on-year increase of 12.86%. For the first three quarters of 2026, operating revenue was RMB 2.501 billion, a year-on-year increase of 3.67%. Net profit attributable to shareholders of listed companies was RMB 670 million, a year-on-year increase of 21.72%. Net profit excluding non-recurring gains and losses was RMB 537 million, a year-on-year increase of 8.44%.